Kither Biotech

Lungs
#Kither Biotech #Peptides #Phase I trial #Respiratory

Kither completes Phase I trial of inhaled peptide therapy

Kither Biotech has announced the successful completion of its Phase I clinical study of KIT2014 for respiratory diseases in healthy participants.  “We are pleased to report the successful completion of this first-in-human Phase I study with KIT2014, a significant milestone for Kither Biotech,” said Dr Dimitrios Goundis,… Read More

#News

Double stranded DNA molecule with mutation in a gene
#Clinical trials #Cystic fibrosis #Drug delivery #Drug development #Europe #Kither Biotech

In Conversation With: Dimitrios Goundis, Kither Biotech

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Dimitrios Goundis, CEO… Read More

#News